Burn size determines the inflammatory and hypermetabolic response.
BACKGROUND
Increased burn size leads to increased mortality of burned patients. Whether mortality is due to inflammation, hypermetabolism or other pathophysiologic contributing factors is not entirely determined. The purpose of the present study was to determine in a large prospective clinical trial whether different burn sizes are associated with differences in inflammation, body composition, protein synthesis, or organ function.


METHODS
Pediatric burned patients were divided into four burn size groups: <40% total body surface area (TBSA) burn, 40-59% TBSA burn, 60-79% TBSA burn, and >80% TBSA burn. Demographic and clinical data, hypermetabolism, the inflammatory response, body composition, the muscle protein net balance, serum and urine hormones and proteins, and cardiac function and changes in liver size were determined.


RESULTS
One hundred and eighty-nine pediatric patients of similar age and gender distribution were included in the study (<40% TBSA burn, n = 43; 40-59% TBSA burn, n = 79; 60-79% TBSA burn, n = 46; >80% TBSA burn, n = 21). Patients with larger burns had more operations, a greater incidence of infections and sepsis, and higher mortality rates compared with the other groups (P < 0.05). The percentage predicted resting energy expenditure was highest in the >80% TBSA group, followed by the 60-79% TBSA burn group (P < 0.05). Children with >80% burns lost the most body weight, lean body mass, muscle protein and bone mineral content (P < 0.05). The urine cortisol concentration was highest in the 80-99% and 60-79% TBSA burn groups, associated with significant myocardial depression and increased change in liver size (P < 0.05). The cytokine profile showed distinct differences in expression of IL-8, TNF, IL-6, IL-12p70, monocyte chemoattractant protein-1 and granulocyte-macrophage colony-stimulating factor (P < 0.05).


CONCLUSIONS
Morbidity and mortality in burned patients is burn size dependent, starts at a 60% TBSA burn and is due to an increased hypermetabolic and inflammatory reaction, along with impaired cardiac function.
Jeschke
Marc G
MG
Shriners Hospitals for Children, 815 Market Street, Galveston, TX 77550, USA. majeschk@utmb.edu
Mlcak
Ronald P
RP
Finnerty
Celeste C
CC
Norbury
William B
WB
Gauglitz
Gerd G
GG
Kulp
Gabriela A
GA
Herndon
David N
DN
D001823:Body Composition; D002056:Burns / Q000145:classification* / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology*; D002153:Calorimetry, Indirect; D002648:Child; D016207:Cytokines / Q000097:blood; D004734:Energy Metabolism; D005260:Female; D006321:Heart / Q000503:physiopathology; D006728:Hormones / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology*; D008099:Liver / Q000503:physiopathology; D008297:Male; D009124:Muscle Proteins / Q000378:metabolism; D011446:Prospective Studies; D014176:Protein Biosynthesis; D013781:Texas / Q000453:epidemiology
D016207:Cytokines; D006728:Hormones; D009124:Muscle Proteins
J Trauma. 1999 Nov;47(5):904-10; discussion 910-1
10568720
Am Surg. 1966 Jul;32(7):448-52
5938617
World J Surg. 2000 Jun;24(6):673-80
10773119
Ann Nutr Metab. 2000;44(1):21-9
10838463
Ann Surg. 2000 Oct;232(4):455-65
10998644
J Trauma. 2000 Oct;49(4):673-7; discussion 677-8
11038085
Crit Care Med. 2001 Jul;29(7):1318-24
11445678
J Trauma. 2001 Sep;51(3):540-4
11535907
N Engl J Med. 2001 Nov 8;345(19):1359-67
11794168
Shock. 2001 Nov;16(5):373-9
11699076
Ann Surg. 2002 Jan;235(1):152-61
11753055
Regul Pept. 2002 May 15;105(2):75-81
11891007
Shock. 2002 Sep;18(3):272-6
12353930
Mol Med. 2002 May;8(5):238-46
12359954
Crit Care Med. 2002 Nov;30(11):2438-42
12441751
Ann Surg. 1974 Oct;180(4):653-69
4412350
Surg Clin North Am. 1976 Oct;56(5):999-1018
982246
Br Med Bull. 1985 Jul;41(3):257-64
3896381
J Clin Invest. 1986 Mar;77(3):900-7
2869053
Am J Physiol. 1986 Mar;250(3 Pt 1):E306-11
2869694
Ann Surg. 1992 Sep;216(3):353-61; discussion 361-2
1329681
Clin Sci (Lond). 1993 Jun;84(6):655-61
8334812
J Trauma. 1993 Oct;35(4):605-12
8411286
Ann Surg. 1994 Jun;219(6):715-22; discussion 722-4
8203982
Am J Physiol. 1995 Jan;268(1 Pt 1):E75-84
7840186
Am J Physiol. 1995 Mar;268(3 Pt 1):E514-20
7900797
Diabete Metab. 1995 Dec;21(5):330-7
8586149
Am J Physiol. 1997 Jul;273(1 Pt 1):E122-9
9252488
Nutrition. 1997 Sep;13(9 Suppl):52S-57S
9290110
Biochem Biophys Res Commun. 1998 Feb 4;243(1):269-72
9473516
Ann Surg. 1999 May;229(5):713-20; discussion 720-2
10235530
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1998 May;14(3):211-3
10452069
Ann Surg. 1957 Apr;145(4):479-87
13412024
J Physiol. 1949 Aug;109(1-2):1-9
15394301
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H795-804
15388499
Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R656-62
15539610
Int J Biochem Cell Biol. 2005 Oct;37(10):1948-61
16109499
N Engl J Med. 2006 Feb 2;354(5):449-61
16452557
J Am Coll Surg. 2006 Mar;202(3):536-48
16500259
J Trauma. 2006 May;60(5):968-71; discussion 971
16688056
Shock. 2006 Jul;26(1):13-9
16783192
Lancet. 2004 Jun 5;363(9424):1895-902
15183630
Ann Surg. 2000 Mar;231(3):408-16
10714634